【肺癌】利用機器學習預測NSCLC末期患者接受ICI治療後發生免疫相關不良事件風險

 【肺癌】利用機器學習預測NSCLC末期患者接受ICI治療後發生免疫相關不良事件風險

 文章出處  

Frontiers in Oncology 

 

 原文標題  

Development of an online prediction tool for immunotherapy-related adverse events in patients with advanced NSCLC based on machine learning and temporal validation 

 

 文章序號  

11676 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2026 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.